Shoprite director's associate sells shares, enters scrip loan

Titan Fincap Solutions (RF) (Pty) Ltd, an associate of Shoprite Holdings non-executive director Dr. CH Wiese, conducted an on-market sale of 3,831,164 ordinary shares on October 2, 2025. The shares were sold at R278.50 per security, totaling R1,066,979,174.00. Dr. Wiese's interest in this transaction is indirect beneficial, as Titan Fincap is controlled by Titan Premier Investment (Pty) Ltd, where Dr. Wiese is a director. Clearance to deal was obtained for this transaction.

Concurrently, on October 3, 2025, Titan Fincap entered into a "Third Scrip Loan" by borrowing 3,831,164 Shoprite Holdings ordinary shares on the market. The deemed price per borrowed security for this arrangement is R278.50, based on the sale price of the ordinary shares referenced in the earlier transaction. The total value of this scrip borrow transaction also amounts to R1,066,979,174.00.

Dr. Wiese’s interest for this scrip borrow is indirect beneficial through Titan Fincap. This dealing was disclosed in compliance with JSE Limited Listings Requirements. The announcement was made from Cape Town on October 6, 2025, with Nedbank Corporate and Investment Banking acting as the sponsor.